Overview

A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and tolerability of MEDI-563 in adults with asthma and the effects of MEDI-563 on eosinophil counts in airway mucosal biopsies
Phase:
Phase 1
Details
Lead Sponsor:
MedImmune LLC
Treatments:
Benralizumab